Loading...
Loading...
Investing is risky. You might not know what you'll earn, it could be hard to sell, you might own less, unexpected things can happen, and you could lose all your money.
MedPlanner
MedPlanner offers the first all-in-one clinical app to manage patients. A platform that facilitates collaboration across clinicians throughout the world to overcome problems faced by the current healthcare communication by using ground-breaking app to improve patient care.
First-Mover Deal ! Within the first 30 days of the fundraising campaign and/or upon the campaign reaching 25% of its funding target, MedPlanner will reward investors with 10% additional shares from the promoters for all individual investments of RM1,255 and above. |
MedPlanner offers the first all-in-one clinical app to manage patients. A platform that facilitates collaboration across clinicians throughout the world to overcome problems faced by the current healthcare communication by using ground-breaking app to improve patient care.
First-Mover Deal ! Within the first 30 days of the fundraising campaign and/or upon the campaign reaching 25% of its funding target, MedPlanner will reward investors with 10% additional shares from the promoters for all individual investments of RM1,255 and above. |
Business Information
Registered Name
MEDPLANNER SDN BHD
Registration No.
201701038564 (1252735-W)
Business Address
No 6, Changkat Semantan, Bukit Damansara, 50490 Kuala Lumpur, Malaysia
MIN INVESTMENT
RM 1,255
MIN TARGET
RM 800,000
MAX TARGET
RM 1,500,000
SHARE TYPE
Ordinary Shares
SHARE PRICE
RM 125.5
VALUATION
RM 12,550,000
Medplanner Sdn Bhd was incorporated in Malaysia in 2017 to develop and commercialise a digital healthcare communication platform. The platform is designed to improve communication and collaboration among healthcare professionals, enhance operational efficiency, and support better patient care.
Building on its earlier development and research in the UK, Medplanner aims to deliver an all-in-one digital solution for healthcare professionals, with the potential to expand across regional and global markets.
Medplanner is solving the problems of healthcare inefficiency arising from poor communication. At the heart of medical provision is team collaboration. Unfortunately, there is no good clinical communication system available. As the result, the impact of poor communication in healthcare can be seen as follows:
On daily basis, clinicians had to put up with :
Use of Whatsapp or similar chat apps
Archaic patient management structure
Delays in receiving clinical updates and information
Reference:
Our growth strategy has core elements which will primarily drive user numbers:
ORGANIC GROWTH
Our most responsive revenue needle comes from organic growth that comes from user invitations into Medplanner. Owing to the virality design of our chat app, we project that organic user acquisition via user-to-user invitations will be grow between 20% to 30% new per month at a deceearsing rate in the first 2 years in a new market.
BRANDING
Medplanner’s brand personality is shows competence and reliability of our service. We leverage ion the strengths of influencers, usually lead doctors in their areas of expertise or in the or workplace to help us advocate the usage of our app. To date, several doctors from various hospitals who have used our earlier version Hailadoc have expressed their interest in implementing Medplanner as their new patient management tool.
TARGET USERS
We are raising funds for the purpose of further product development and marketing activities. We plan to expand our current headcount of 4 team members to 9 people in 2019 to help facilitate our growth plan. The fund allocation breakdown details are as follows:
![[MDP] Drawing (6).png](https://pxngcctamapirzokxdpu.supabase.co/storage/v1/object/public/deal-images/uploads/upudirxbwb-1787820362287.png)
Co-Founder & CEO
Co-Founder & CTO
Co-Founder & CGO
Medplanner Sdn Bhd, a private limited company incorporated in Malaysia
MedPlanner offers the first all-in-one clinical app to manage patients. A platform that facilitates collaboration across clinicians throughout the world to overcome problems faced by the current healthcare communication by using ground-breaking app to improve patient care.
Ordinary Shares
88 days
The Issuer intends to raise up to RM 1,500,000 in this fundraising exercise.
RM 800,000
RM 1,500,000
RM 125.5 per share
6,375 shares
11,952 shares
RM 1,255
Angel, Sophisticated, and/or Institutional Investors, subject to the applicable investment limits prescribed under the Securities Commission’s Guidelines on Recognised Markets.
The proceeds are intended to be used for product and network development, branding growth and marketing as well as overhead costs. The funds will be transferred to the Issuer by the end of the Closing Date.
14 working days after the end of the Fundraising Period.
An Investment Agreement to subscribe ordinary shares and subject to review if required or necessary, the procedure may be amended by the Issuer and the ECF Platform.
The information, calculations and remarks expressed on this term sheet or on any other part of the platform are based on information provided, disclosed and presented by Medplanner Sdn Bhd to Ata Plus Sdn Bhd, either in part or in whole. Ata Plus disclaims responsibility for the accuracy, completeness and/or validity of these information, and hence will not be held liable for any inaccurate, inappropriate or incomplete information presented on this term sheet or on any other part of the platform subject to the following:
The financial information listed on the deal page is provided by the Issuer; which includes the financial forecasts and projections, the capitalization table, the term sheet, and management accounts.
The financial forecasts and projections have been prepared by the issuer based on assumptions that have not been reviewed and certified by an independent certified accountant for its reasonableness.
THE ISSUER agrees that; all information concerning the product, business and the assets of THE ISSUER that have been furnished to Ata Plus Sdn Bhd for the purpose of the equity crowdfunding campaign is true, complete, and accurate in all material respect and is not misleading or deceptive whether by inclusion or omission.
Should the Investor require more information, they can do so by contacting Medplanner Sdn Bhd directly at danil@medplanner.io.
(i) No shares will be alotted or issued based on this document after six months from the closing of the offer period
(ii) This issue, offer or invitation for the offering is a proposal not requiring authorisation of the Securities Commission under section 212(8) of the CMSA 2007
(iii) This document has not been reviewed by the Securities Commission Malaysia. The Securities Commission does not recommend nor assumes responsibility for any information including any statement, opinion or report disclosed in relation to this fund raising exercise and makes no representation as to its accuracy or completeness. The Securities Commission expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information disclosed.
Investors will receive an additional 10% shares* of the investment made
*these are shares to be subscribed for and paid by the promoters i.e. the existing shareholders of Medplanner Sdn Bhd
Investment Amount: RM 1,255 to RM 5,000
Reward(s)
Investment Amount: RM 6,000 to RM 10,000
Reward(s)
Investment Amount: RM 15,000 to RM 30,000
Reward(s)
Investment Amount: RM 50,000 to RM 200,000
Reward(s)
Investment Amount: RM 300,000 to RM 1,000,000
Reward(s)
Investment Amount: RM 1,500,000
Reward(s)
RM 1,000,000
of RM 800,000
Min Target
RM 800,000
Max Target
RM 1,500,000
Business Information
Registered Name
MEDPLANNER SDN BHD
Registration No.
201701038564 (1252735-W)
Business Address
No 6, Changkat Semantan, Bukit Damansara, 50490 Kuala Lumpur, Malaysia
Investing in equity crowdfunding involves certain risks that include uncertainty of returns, lack of liquidity, dilution, material events and lack of control. Investments should be done as part of a diversified portfolio. ATA PLUS offers investment opportunities to investors who understands these risks in making their own investment decisions.
PLEASE READ THE FULL RISK WARNING BEFORE DECIDING TO INVEST.
This page is approved as a financial promotion by ATA PLUS Sdn. Bhd., which is authorized and regulated by the Security Commission of Malaysia. Deals that are up for investment are only offered to members of ata-plus.com on the basis of information provided by the companies concerned. ATA PLUS takes no responsibility for this information or for any recommendations or opinions made by the companies. For further information on this, please read our Term of Use.
RM 1,000,000
of RM 800,000
Min Target
RM 800,000
Max Target
RM 1,500,000
Min Investment
RM 1,255